Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Cognetti

Showing results (41-50 of 275) with videos related to

Pageof 28
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|May 6, 2003
Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumorsSerena Di Cosimo, Gianluigi Ferretti, Paola Papaldo, et al.
Breast Care (Basel, Switzerland)|August 12, 2022
Second-Degree Type 2 Atrioventricular Block Requiring Permanent Cardiac Pacing in Patients on CDK4/6 Inhibitors: Report of Two CasesMaria Paola Cicini, Gianluigi Ferretti, Nicola Morace, et al.
The Lancet. Oncology|April 1, 2006
Severe rhabdomyolysis associated with pemetrexed-based chemotherapyAnna Ceribelli, Fabiana Letizia Cecere, Michele Milella, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 26, 2008
The withdrawal from oncogenetic counselling and testing for hereditary and familial breast and ovarian cancer. A descriptive study of an Italian sampleAnita Caruso, Cristina Vigna, Gabriella Maggi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
Should subgroup analysis of randomized clinical trials have a direct impact on clinical practice?Emilio Bria, Massimo Di Maio, Federica Cuppone, et al.
Anticancer Research|July 15, 2009
Pseudoprogression and MGMT status in glioblastoma patients: implications in clinical practiceAlessandra Fabi, Michelangelo Russillo, Giulio Metro, et al.
The International Journal of Biochemistry & Cell Biology|September 12, 2006
Human malignant mesothelioma: molecular mechanisms of pathogenesis and progressionEnrico P Spugnini, Silvano Bosari, Gennaro Citro, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
The Role of Homologous Recombination Deficiency (HRD) in Renal Cell Carcinoma (RCC): Biology, Biomarkers, and Therapeutic OpportunitiesAlberto Bongiovanni, Pierfranco Conte, Vincenza Conteduca, et al.
Journal of the National Cancer Institute|November 21, 2002
Re: Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancerGianluigi Ferretti, Serena Di Cosimo, Paolo Carlini, et al.
Thrombosis Research|October 7, 2006
Self-monitoring versus standard monitoring of oral anticoagulationGianluigi Ferretti, Diana Giannarelli, Paolo Carlini, et al.
Pageof 28

Showing results (41-50 of 275) with videos related to

Sort By:
Pageof 28
Drugs of Today (Barcelona, Spain : 1998)|May 6, 2003
Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumorsSerena Di Cosimo, Gianluigi Ferretti, Paola Papaldo, et al.
Breast Care (Basel, Switzerland)|August 12, 2022
Second-Degree Type 2 Atrioventricular Block Requiring Permanent Cardiac Pacing in Patients on CDK4/6 Inhibitors: Report of Two CasesMaria Paola Cicini, Gianluigi Ferretti, Nicola Morace, et al.
The Lancet. Oncology|April 1, 2006
Severe rhabdomyolysis associated with pemetrexed-based chemotherapyAnna Ceribelli, Fabiana Letizia Cecere, Michele Milella, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 26, 2008
The withdrawal from oncogenetic counselling and testing for hereditary and familial breast and ovarian cancer. A descriptive study of an Italian sampleAnita Caruso, Cristina Vigna, Gabriella Maggi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
Should subgroup analysis of randomized clinical trials have a direct impact on clinical practice?Emilio Bria, Massimo Di Maio, Federica Cuppone, et al.
Anticancer Research|July 15, 2009
Pseudoprogression and MGMT status in glioblastoma patients: implications in clinical practiceAlessandra Fabi, Michelangelo Russillo, Giulio Metro, et al.
The International Journal of Biochemistry & Cell Biology|September 12, 2006
Human malignant mesothelioma: molecular mechanisms of pathogenesis and progressionEnrico P Spugnini, Silvano Bosari, Gennaro Citro, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
The Role of Homologous Recombination Deficiency (HRD) in Renal Cell Carcinoma (RCC): Biology, Biomarkers, and Therapeutic OpportunitiesAlberto Bongiovanni, Pierfranco Conte, Vincenza Conteduca, et al.
Journal of the National Cancer Institute|November 21, 2002
Re: Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancerGianluigi Ferretti, Serena Di Cosimo, Paolo Carlini, et al.
Thrombosis Research|October 7, 2006
Self-monitoring versus standard monitoring of oral anticoagulationGianluigi Ferretti, Diana Giannarelli, Paolo Carlini, et al.
Pageof 28